@Flex68 thinks the Celgene share buyback - $CELG - will drive the share price higher....CELG's BOD authorized an additional $5b in buybacks in mid-February, and then on May 24 they authorized another $3b in buybacks, with $2b of that to be 'accelerated stock repurchase.' (The planned ASR to utilize part of the existing Board authorized share repurchase program (from Feb.) as well as part of the new authorization.) $CELG, Celgene Corporation / H1 From their last annual 10-k: During the three-month period ended December 31, 2017, we purchased approximately 29.0 million shares of common stock under the share repurchase program from all sources at a cost of approximately $3.0 billion. Basic weighted average shares: 779.2 million Then, from their 10-Q of March 31, 2018 : Basic weighted average shares: 748.3 million If one averages SP out to around $90 during the first 3 months of 2018, the above share change would equate to nearly $3b in buybacks.If that estimation is anywhere near to correct, they should have $2b remaining from the initial $5b plan of mid-Feb, and another $3b from the additional of May 24....... so that would leave them with about another $5b remaining. Great time for them to be using that money to repurchase shares!! Ignoring everything else, changing the float by such a significant amount is going to add real value for shareholders...... one has to believe that IF the SP has 'bottomed' that this is a fantastic opportunity to buy!...Related: $REGN - Regeneron is in a downtrend. $GILD - Gilead is getting no bids from investors. $AGN - Allergan is at a discount.Buy Celgene: Agree or disagree? Login now to vote. Join the group of Value Stocks. With ~830 members. Comment below. Your posts are heard amongst the members.